IBSA laboratories have developed the SINOVIAL gamma: a substitute for synovial fluid for infiltrative therapies in case of joint suffering or post-traumatic conditions. The pre-filled syringe technology simplifies the administration of the product, perfectly sterile, reducing the risk of errors, consequently improving safety.
SAFE AND CUTTING-EDGE TECHNOLOGY FOR THE OSTEOARTICULAR AREA
Do you want to know more?
Fill the form to contact us
IBSA Business Development
Since 2018, there has been a new Department in IBSA fully dedicated to Business Development, Licensing activities and CDMO projects. Licensing The Business Development Dept. is constantly looking for partners and international distributors for licensing agreements in countries where IBSA does not operate directly with its branches. IBSA is focused on strategic collaborations to achieve a common goal while sharing responsibilities, resources, risks and rewards. Close ties with local distributors are crucial for IBSA to grow at an international level. The Business Development Dept. also evaluates licensing-in opportunities for the expansion of product portfolio.
Thanks to its consolidated experience, its industrial capacity and its proprietary technologies, IBSA is the ideal partner to serve other companies in the pharmaceutical industry, on a contract basis, providing comprehensive services from drug development through drug manufacturing for EU and non-EU markets.
IBSA provides a customized service consisting of:
- product concept and pre-formulation
- formulation and process development
- development and validation of the analytical method
- pre-clinical investigation
- pilot and scale batches
- clinical batches
- studies and stability test
- scientific and regulatory assistance IBSA has a great experience in all product categories:
1. drugs: – OTC – ethical drugs
2. medical devices